Inve US ▾
GEGERN

Geron (GERN) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 5, 2026

Source: earnings call transcript

Geron delivered a strong second quarter, driven by robust RYTELO net revenue growth and disciplined financial management. The company is expanding RYTELO's reach in the US, exploring European commercialization strategies, and advancing its Phase III IMPACT MF program. Management anticipates full-year net revenue to be at the mid-to-high end of its guidance range, reflecting confidence in its commercial execution and strategic priorities.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.